GO:0004151 | dihydroorotase activity | 5.12e-04 | 1.00e+00 | 10.931 | 1 | 1 | 1 |
GO:0004070 | aspartate carbamoyltransferase activity | 5.12e-04 | 1.00e+00 | 10.931 | 1 | 1 | 1 |
GO:0004088 | carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity | 5.12e-04 | 1.00e+00 | 10.931 | 1 | 1 | 1 |
GO:0070335 | aspartate binding | 5.12e-04 | 1.00e+00 | 10.931 | 1 | 1 | 1 |
GO:0070409 | carbamoyl phosphate biosynthetic process | 5.12e-04 | 1.00e+00 | 10.931 | 1 | 1 | 1 |
GO:0044205 | 'de novo' UMP biosynthetic process | 1.54e-03 | 1.00e+00 | 9.347 | 1 | 1 | 3 |
GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process | 1.54e-03 | 1.00e+00 | 9.347 | 1 | 1 | 3 |
GO:0006543 | glutamine catabolic process | 1.54e-03 | 1.00e+00 | 9.347 | 1 | 1 | 3 |
GO:0000398 | mRNA splicing, via spliceosome | 1.66e-03 | 1.00e+00 | 4.931 | 2 | 8 | 128 |
GO:0000405 | bubble DNA binding | 2.05e-03 | 1.00e+00 | 8.931 | 1 | 1 | 4 |
GO:0051414 | response to cortisol | 2.05e-03 | 1.00e+00 | 8.931 | 1 | 1 | 4 |
GO:0006228 | UTP biosynthetic process | 2.05e-03 | 1.00e+00 | 8.931 | 1 | 1 | 4 |
GO:0014075 | response to amine | 2.56e-03 | 1.00e+00 | 8.610 | 1 | 1 | 5 |
GO:0043140 | ATP-dependent 3'-5' DNA helicase activity | 2.56e-03 | 1.00e+00 | 8.610 | 1 | 1 | 5 |
GO:0008380 | RNA splicing | 2.74e-03 | 1.00e+00 | 4.565 | 2 | 7 | 165 |
GO:0046134 | pyrimidine nucleoside biosynthetic process | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 6 |
GO:0001055 | RNA polymerase II activity | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 2 | 6 |
GO:0031000 | response to caffeine | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 6 |
GO:0036310 | annealing helicase activity | 3.58e-03 | 1.00e+00 | 8.124 | 1 | 1 | 7 |
GO:0070063 | RNA polymerase binding | 3.58e-03 | 1.00e+00 | 8.124 | 1 | 1 | 7 |
GO:0005634 | nucleus | 4.05e-03 | 1.00e+00 | 1.589 | 5 | 67 | 3246 |
GO:0000733 | DNA strand renaturation | 4.09e-03 | 1.00e+00 | 7.931 | 1 | 2 | 8 |
GO:0006281 | DNA repair | 4.13e-03 | 1.00e+00 | 4.266 | 2 | 19 | 203 |
GO:0043234 | protein complex | 4.41e-03 | 1.00e+00 | 4.217 | 2 | 8 | 210 |
GO:0021591 | ventricular system development | 4.60e-03 | 1.00e+00 | 7.762 | 1 | 1 | 9 |
GO:0008266 | poly(U) RNA binding | 4.60e-03 | 1.00e+00 | 7.762 | 1 | 1 | 9 |
GO:0005736 | DNA-directed RNA polymerase I complex | 5.11e-03 | 1.00e+00 | 7.610 | 1 | 2 | 10 |
GO:0001054 | RNA polymerase I activity | 5.11e-03 | 1.00e+00 | 7.610 | 1 | 2 | 10 |
GO:0006541 | glutamine metabolic process | 5.11e-03 | 1.00e+00 | 7.610 | 1 | 1 | 10 |
GO:0045120 | pronucleus | 5.62e-03 | 1.00e+00 | 7.472 | 1 | 1 | 11 |
GO:0070935 | 3'-UTR-mediated mRNA stabilization | 5.62e-03 | 1.00e+00 | 7.472 | 1 | 2 | 11 |
GO:0046827 | positive regulation of protein export from nucleus | 5.62e-03 | 1.00e+00 | 7.472 | 1 | 1 | 11 |
GO:0005665 | DNA-directed RNA polymerase II, core complex | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 2 | 13 |
GO:0001056 | RNA polymerase III activity | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 2 | 13 |
GO:0005666 | DNA-directed RNA polymerase III complex | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 2 | 13 |
GO:0006385 | transcription elongation from RNA polymerase III promoter | 7.15e-03 | 1.00e+00 | 7.124 | 1 | 2 | 14 |
GO:0006386 | termination of RNA polymerase III transcription | 7.15e-03 | 1.00e+00 | 7.124 | 1 | 2 | 14 |
GO:0001944 | vasculature development | 8.68e-03 | 1.00e+00 | 6.844 | 1 | 1 | 17 |
GO:0006206 | pyrimidine nucleobase metabolic process | 8.68e-03 | 1.00e+00 | 6.844 | 1 | 2 | 17 |
GO:0033574 | response to testosterone | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 1 | 18 |
GO:0071364 | cellular response to epidermal growth factor stimulus | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 1 | 18 |
GO:0045596 | negative regulation of cell differentiation | 1.02e-02 | 1.00e+00 | 6.610 | 1 | 1 | 20 |
GO:0043044 | ATP-dependent chromatin remodeling | 1.02e-02 | 1.00e+00 | 6.610 | 1 | 2 | 20 |
GO:0006362 | transcription elongation from RNA polymerase I promoter | 1.02e-02 | 1.00e+00 | 6.610 | 1 | 1 | 20 |
GO:0006363 | termination of RNA polymerase I transcription | 1.07e-02 | 1.00e+00 | 6.539 | 1 | 1 | 21 |
GO:0017144 | drug metabolic process | 1.07e-02 | 1.00e+00 | 6.539 | 1 | 1 | 21 |
GO:0006361 | transcription initiation from RNA polymerase I promoter | 1.17e-02 | 1.00e+00 | 6.408 | 1 | 1 | 23 |
GO:0042802 | identical protein binding | 1.22e-02 | 1.00e+00 | 3.464 | 2 | 7 | 354 |
GO:0006370 | 7-methylguanosine mRNA capping | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 2 | 24 |
GO:0048839 | inner ear development | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 2 | 24 |
GO:0031492 | nucleosomal DNA binding | 1.27e-02 | 1.00e+00 | 6.288 | 1 | 2 | 25 |
GO:0003730 | mRNA 3'-UTR binding | 1.27e-02 | 1.00e+00 | 6.288 | 1 | 2 | 25 |
GO:0006360 | transcription from RNA polymerase I promoter | 1.38e-02 | 1.00e+00 | 6.177 | 1 | 2 | 27 |
GO:0018107 | peptidyl-threonine phosphorylation | 1.48e-02 | 1.00e+00 | 6.073 | 1 | 2 | 29 |
GO:0006383 | transcription from RNA polymerase III promoter | 1.48e-02 | 1.00e+00 | 6.073 | 1 | 2 | 29 |
GO:0016020 | membrane | 1.55e-02 | 1.00e+00 | 2.279 | 3 | 38 | 1207 |
GO:0043195 | terminal bouton | 1.58e-02 | 1.00e+00 | 5.977 | 1 | 1 | 31 |
GO:0007595 | lactation | 1.63e-02 | 1.00e+00 | 5.931 | 1 | 2 | 32 |
GO:0050434 | positive regulation of viral transcription | 1.78e-02 | 1.00e+00 | 5.802 | 1 | 2 | 35 |
GO:0035690 | cellular response to drug | 1.93e-02 | 1.00e+00 | 5.684 | 1 | 2 | 38 |
GO:0032508 | DNA duplex unwinding | 1.93e-02 | 1.00e+00 | 5.684 | 1 | 5 | 38 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 2.03e-02 | 1.00e+00 | 5.610 | 1 | 6 | 40 |
GO:0042995 | cell projection | 2.08e-02 | 1.00e+00 | 5.574 | 1 | 2 | 41 |
GO:0031100 | organ regeneration | 2.23e-02 | 1.00e+00 | 5.472 | 1 | 2 | 44 |
GO:0060021 | palate development | 2.38e-02 | 1.00e+00 | 5.377 | 1 | 1 | 47 |
GO:0032481 | positive regulation of type I interferon production | 2.43e-02 | 1.00e+00 | 5.347 | 1 | 5 | 48 |
GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding | 2.48e-02 | 1.00e+00 | 5.317 | 1 | 3 | 49 |
GO:0006310 | DNA recombination | 2.53e-02 | 1.00e+00 | 5.288 | 1 | 6 | 50 |
GO:0006334 | nucleosome assembly | 2.58e-02 | 1.00e+00 | 5.259 | 1 | 4 | 51 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 2.58e-02 | 1.00e+00 | 5.259 | 1 | 5 | 51 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 2.63e-02 | 1.00e+00 | 5.231 | 1 | 3 | 52 |
GO:0010467 | gene expression | 2.68e-02 | 1.00e+00 | 2.868 | 2 | 31 | 535 |
GO:0006289 | nucleotide-excision repair | 2.69e-02 | 1.00e+00 | 5.204 | 1 | 9 | 53 |
GO:0042393 | histone binding | 2.74e-02 | 1.00e+00 | 5.177 | 1 | 3 | 54 |
GO:0005681 | spliceosomal complex | 2.79e-02 | 1.00e+00 | 5.150 | 1 | 2 | 55 |
GO:0071013 | catalytic step 2 spliceosome | 3.09e-02 | 1.00e+00 | 5.001 | 1 | 5 | 61 |
GO:0007565 | female pregnancy | 3.23e-02 | 1.00e+00 | 4.931 | 1 | 2 | 64 |
GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process | 3.38e-02 | 1.00e+00 | 4.865 | 1 | 2 | 67 |
GO:0001889 | liver development | 3.58e-02 | 1.00e+00 | 4.782 | 1 | 1 | 71 |
GO:0070062 | extracellular vesicular exosome | 3.63e-02 | 1.00e+00 | 1.836 | 3 | 43 | 1641 |
GO:0016363 | nuclear matrix | 3.68e-02 | 1.00e+00 | 4.742 | 1 | 7 | 73 |
GO:0001649 | osteoblast differentiation | 3.73e-02 | 1.00e+00 | 4.722 | 1 | 2 | 74 |
GO:0005829 | cytosol | 4.57e-02 | 1.00e+00 | 1.713 | 3 | 58 | 1787 |
GO:0006260 | DNA replication | 4.72e-02 | 1.00e+00 | 4.377 | 1 | 11 | 94 |
GO:0008270 | zinc ion binding | 4.76e-02 | 1.00e+00 | 2.426 | 2 | 7 | 727 |
GO:0007507 | heart development | 5.31e-02 | 1.00e+00 | 4.204 | 1 | 1 | 106 |
GO:0046777 | protein autophosphorylation | 5.31e-02 | 1.00e+00 | 4.204 | 1 | 2 | 106 |
GO:0000790 | nuclear chromatin | 5.46e-02 | 1.00e+00 | 4.163 | 1 | 3 | 109 |
GO:0004672 | protein kinase activity | 6.24e-02 | 1.00e+00 | 3.966 | 1 | 2 | 125 |
GO:0005654 | nucleoplasm | 6.69e-02 | 1.00e+00 | 2.157 | 2 | 55 | 876 |
GO:0005524 | ATP binding | 6.92e-02 | 1.00e+00 | 2.131 | 2 | 23 | 892 |
GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 7.06e-02 | 1.00e+00 | 3.782 | 1 | 2 | 142 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 7.98e-02 | 1.00e+00 | 3.601 | 1 | 4 | 161 |
GO:0043025 | neuronal cell body | 8.46e-02 | 1.00e+00 | 3.514 | 1 | 3 | 171 |
GO:0000166 | nucleotide binding | 8.69e-02 | 1.00e+00 | 3.472 | 1 | 6 | 176 |
GO:0019899 | enzyme binding | 1.03e-01 | 1.00e+00 | 3.217 | 1 | 4 | 210 |
GO:0007275 | multicellular organismal development | 1.05e-01 | 1.00e+00 | 3.190 | 1 | 4 | 214 |
GO:0006200 | ATP catabolic process | 1.07e-01 | 1.00e+00 | 3.157 | 1 | 8 | 219 |
GO:0005730 | nucleolus | 1.20e-01 | 1.00e+00 | 1.682 | 2 | 41 | 1217 |
GO:0003723 | RNA binding | 1.20e-01 | 1.00e+00 | 2.983 | 1 | 11 | 247 |
GO:0006366 | transcription from RNA polymerase II promoter | 1.63e-01 | 1.00e+00 | 2.518 | 1 | 6 | 341 |
GO:0016032 | viral process | 2.01e-01 | 1.00e+00 | 2.190 | 1 | 32 | 428 |
GO:0045087 | innate immune response | 2.11e-01 | 1.00e+00 | 2.111 | 1 | 7 | 452 |
GO:0044822 | poly(A) RNA binding | 3.47e-01 | 1.00e+00 | 1.289 | 1 | 25 | 799 |
GO:0044281 | small molecule metabolic process | 3.64e-01 | 1.00e+00 | 1.210 | 1 | 32 | 844 |
GO:0003677 | DNA binding | 4.00e-01 | 1.00e+00 | 1.044 | 1 | 18 | 947 |
GO:0005737 | cytoplasm | 4.09e-01 | 1.00e+00 | 0.569 | 2 | 50 | 2633 |
GO:0005515 | protein binding | 9.36e-01 | 1.00e+00 | -1.078 | 1 | 76 | 4124 |